HK1221407A1 - 含有聚乙二醇的組合物 - Google Patents
含有聚乙二醇的組合物Info
- Publication number
- HK1221407A1 HK1221407A1 HK16109575.6A HK16109575A HK1221407A1 HK 1221407 A1 HK1221407 A1 HK 1221407A1 HK 16109575 A HK16109575 A HK 16109575A HK 1221407 A1 HK1221407 A1 HK 1221407A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- polyethylene glycol
- containing composition
- composition
- glycol
- polyethylene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013195329 | 2013-09-20 | ||
PCT/JP2014/074698 WO2015041294A1 (ja) | 2013-09-20 | 2014-09-18 | ポリエチレングリコール含有組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1221407A1 true HK1221407A1 (zh) | 2017-06-02 |
Family
ID=52688941
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16108793.4A HK1220632A1 (zh) | 2013-09-20 | 2016-07-21 | 含有聚乙二醇的組合物 |
HK16109575.6A HK1221407A1 (zh) | 2013-09-20 | 2016-08-11 | 含有聚乙二醇的組合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16108793.4A HK1220632A1 (zh) | 2013-09-20 | 2016-07-21 | 含有聚乙二醇的組合物 |
Country Status (17)
Country | Link |
---|---|
US (1) | US20160228420A1 (zh) |
EP (1) | EP3047850A4 (zh) |
JP (2) | JP5856264B2 (zh) |
KR (1) | KR20160060656A (zh) |
CN (1) | CN105555271A (zh) |
AU (1) | AU2014322111A1 (zh) |
BR (1) | BR112016006153A2 (zh) |
CA (1) | CA2924628A1 (zh) |
EA (1) | EA201690621A1 (zh) |
HK (2) | HK1220632A1 (zh) |
IL (1) | IL244648A0 (zh) |
MX (1) | MX2016003566A (zh) |
MY (1) | MY163236A (zh) |
PH (1) | PH12016500461A1 (zh) |
SG (1) | SG11201602020QA (zh) |
TW (1) | TW201518291A (zh) |
WO (1) | WO2015041294A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016148201A1 (ja) * | 2015-03-17 | 2016-09-22 | 参天製薬株式会社 | ポリペプチドを含有する医薬組成物 |
KR20170129170A (ko) | 2015-03-18 | 2017-11-24 | 산텐 세이야꾸 가부시키가이샤 | 서방성 의약 조성물 |
JP2017008047A (ja) * | 2015-06-25 | 2017-01-12 | 参天製薬株式会社 | 注射剤 |
US20180185489A1 (en) * | 2015-07-01 | 2018-07-05 | Santen Pharmaceutical Co., Ltd. | Depot preparation containing citric acid ester |
CN106902117A (zh) * | 2015-12-23 | 2017-06-30 | 瑞阳(苏州)生物科技有限公司 | 一种预防或治疗脉络膜新生血管形成的药物 |
EP3515444A4 (en) * | 2016-09-26 | 2020-06-03 | Reyoung (Suzhou) Biology Science & Technology Co., Ltd | COMPOSITION FOR TREATING EYE DISEASES AND METHOD FOR USE AND PRODUCTION |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA833692B (en) * | 1982-05-28 | 1985-02-27 | Beecham Group Plc | Pharmaceutical formulations |
JPS59101478A (ja) * | 1982-11-29 | 1984-06-12 | Sunstar Inc | リグスチライドを安定に配合した水系組成物 |
JPH09110698A (ja) * | 1995-10-19 | 1997-04-28 | Taiho Yakuhin Kogyo Kk | 経口用医薬組成物の製造法 |
ATE512950T1 (de) | 2004-02-17 | 2011-07-15 | Santen Pharmaceutical Co Ltd | Neue cyclische verbindung mit 4- pyridylalkylthiogruppe mit darin eingeführtem (un)substituiertem amino |
JP4626353B2 (ja) * | 2004-02-17 | 2011-02-09 | 参天製薬株式会社 | 置換又は無置換アミノ基を導入した4−ピリジルアルキルチオ基を有する新規環式化合物 |
CN1918127B (zh) * | 2004-02-17 | 2012-02-15 | 参天制药株式会社 | 具有引入了取代或无取代氨基的4-吡啶基烷硫基的环状化合物 |
US20060153920A1 (en) * | 2004-09-24 | 2006-07-13 | Ketan Amin | Lyophilized pharmaceutical compositions |
KR20070104931A (ko) * | 2005-02-09 | 2007-10-29 | 마커사이트, 인코포레이티드 | 안구 치료용 제제 |
US20070149593A1 (en) | 2005-12-23 | 2007-06-28 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
CA2693888A1 (en) | 2007-07-20 | 2009-01-29 | Alcon, Inc. | Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
NZ585499A (en) * | 2007-11-26 | 2011-12-22 | Merial Ltd | Solvent systems for pour-on formulations for combating parasites |
US20100226992A1 (en) | 2009-03-03 | 2010-09-09 | Alcon Research, Ltd. | Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye |
JP5662719B2 (ja) * | 2009-07-17 | 2015-02-04 | 参天製薬株式会社 | 2−[[[2−[(ヒドロキシアセチル)アミノ]−4−ピリジニル]メチル]チオ]−n−[4−(トリフルオロメトキシ)フェニル]−3−ピリジンカルボキサミドのベンゼンスルホン酸塩、その結晶、その結晶多形およびそれらの製造方法 |
LT2528602T (lt) * | 2010-01-28 | 2017-02-27 | Eagle Pharmaceuticals, Inc. | Bendamustino kompozicijos |
-
2014
- 2014-09-18 SG SG11201602020QA patent/SG11201602020QA/en unknown
- 2014-09-18 AU AU2014322111A patent/AU2014322111A1/en not_active Abandoned
- 2014-09-18 TW TW103132199A patent/TW201518291A/zh unknown
- 2014-09-18 MY MYPI2016000477A patent/MY163236A/en unknown
- 2014-09-18 MX MX2016003566A patent/MX2016003566A/es unknown
- 2014-09-18 CN CN201480051151.8A patent/CN105555271A/zh active Pending
- 2014-09-18 US US15/023,207 patent/US20160228420A1/en not_active Abandoned
- 2014-09-18 JP JP2014190339A patent/JP5856264B2/ja not_active Expired - Fee Related
- 2014-09-18 KR KR1020167008149A patent/KR20160060656A/ko not_active Application Discontinuation
- 2014-09-18 WO PCT/JP2014/074698 patent/WO2015041294A1/ja active Application Filing
- 2014-09-18 CA CA2924628A patent/CA2924628A1/en not_active Abandoned
- 2014-09-18 EP EP14845745.0A patent/EP3047850A4/en active Pending
- 2014-09-18 BR BR112016006153A patent/BR112016006153A2/pt not_active IP Right Cessation
- 2014-09-18 EA EA201690621A patent/EA201690621A1/ru unknown
-
2015
- 2015-12-10 JP JP2015240775A patent/JP2016094442A/ja active Pending
-
2016
- 2016-03-09 PH PH12016500461A patent/PH12016500461A1/en unknown
- 2016-03-17 IL IL244648A patent/IL244648A0/en unknown
- 2016-07-21 HK HK16108793.4A patent/HK1220632A1/zh unknown
- 2016-08-11 HK HK16109575.6A patent/HK1221407A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
MY163236A (en) | 2017-08-30 |
CN105555271A (zh) | 2016-05-04 |
TW201518291A (zh) | 2015-05-16 |
JP2015083565A (ja) | 2015-04-30 |
EP3047850A4 (en) | 2017-05-10 |
JP5856264B2 (ja) | 2016-02-09 |
US20160228420A1 (en) | 2016-08-11 |
KR20160060656A (ko) | 2016-05-30 |
BR112016006153A2 (pt) | 2017-08-01 |
SG11201602020QA (en) | 2016-04-28 |
EA201690621A1 (ru) | 2016-07-29 |
IL244648A0 (en) | 2016-04-21 |
EP3047850A1 (en) | 2016-07-27 |
PH12016500461A1 (en) | 2016-05-16 |
WO2015041294A1 (ja) | 2015-03-26 |
HK1220632A1 (zh) | 2017-05-12 |
MX2016003566A (es) | 2016-06-02 |
AU2014322111A1 (en) | 2016-04-07 |
CA2924628A1 (en) | 2015-03-26 |
JP2016094442A (ja) | 2016-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL3065569T3 (pl) | Kompozycja | |
EP2889350A4 (en) | ADHESIVE COMPOSITION | |
HK1214088A1 (zh) | 油脂組合物 | |
HUE044039T2 (hu) | Biokatalitikus készítmény | |
EP3006525A4 (en) | ASPHALT-URETHANE COMPOSITION | |
GB201319540D0 (en) | Composition | |
GB201318489D0 (en) | Composition | |
GB201317388D0 (en) | Composition | |
HK1221407A1 (zh) | 含有聚乙二醇的組合物 | |
GB201320919D0 (en) | Composition | |
GB201306984D0 (en) | Composition | |
EP3066178A4 (en) | GREASE COMPOSITION | |
GB201322772D0 (en) | Composition | |
GB201320303D0 (en) | Composition | |
GB201319538D0 (en) | Composition | |
GB201317105D0 (en) | Novel Composition | |
GB201317196D0 (en) | Composition | |
GB201307622D0 (en) | Composition | |
GB201420672D0 (en) | Composition | |
GB201308502D0 (en) | Composition | |
GB201310513D0 (en) | Novel composition | |
GB201301774D0 (en) | Composition | |
GB201318394D0 (en) | Composition | |
GB201320675D0 (en) | Composition | |
GB201305622D0 (en) | Composition |